Torskal Introduces Groundbreaking Advancements in Nanophototherapy Using Plasmonic Nanoparticles
TORSKAL is an international biotechnology company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy using green chemistry.
- (1888PressRelease) September 25, 2024 - Torskal Nanoscience, a cutting-edge leader in nanotechnology for medical applications, proudly announces a revolutionary breakthrough in Nanophototherapy through the use of plasmonic nanoparticles. This innovative approach marks a significant advancement in cancer treatment, leveraging nanoscience to target and destroy cancer cells more precisely than ever before.
Nanophototherapy is an advanced therapeutic technique that employs light energy to selectively activate nanoparticles in the body, providing a highly targeted and minimally invasive treatment. Torskal's unique application of plasmonic nanoparticles—specialized materials that amplify electromagnetic fields—enables enhanced light absorption and heat generation, which can selectively destroy malignant cells without harming surrounding healthy tissue.
The company's pioneering research demonstrates how plasmonic nanoparticles, when exposed to specific wavelengths of light, can induce localized hyperthermia (heating) at the tumor site, effectively killing cancer cells while minimizing side effects. This targeted approach offers new hope for treating various forms of cancer, especially those resistant to conventional therapies like chemotherapy and radiation.
“Torskal is committed to revolutionizing cancer treatment by harnessing the power of nanotechnology,” said [CEO/TorskalNanoscience], CEO of Torskal Nanoscience. “Our proprietary nanophototherapy technique using plasmonic nanoparticles allows for precision targeting, reducing collateral damage to healthy cells and enhancing patient outcomes.”
About Torskal Nanoscience
Torskal Nanoscience is at the forefront of developing biocompatible and green nanotechnology solutions for medical applications, including cancer treatment. The company focuses on using eco-friendly processes to produce nanoparticles that align with sustainable healthcare. With a mission to enhance therapeutic efficacy while minimizing side effects, Torskal is dedicated to advancing medical science through innovation in nanotechnology.
For more information about Torskal's innovations in nanophototherapy and plasmonic nanoparticles, please visit www.torskal.com or contact:
Media Contact:
Phone: (+262) 262 93 88 31
Email: contact ( @ ) torskal dot com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam